Dr Sarah Knaggs

Dr Sarah Knaggs

Medical and Dental Sciences
Operations Manager (Postgraduate Programmes)

Contact details

Research & Knowledge Transfer Office
Medical School
University of Birmingham
B15 2TT

Sarah is currently providing secondment cover in the role of Operations Manager (Postgraduate Programmes).


  • Certificate in Social Sciences, Open University, 2003
  • PhD in Medicinal Chemistry, Cardiff University, 1999
  • BSc (Hons) in Biomolecular and Biomedical Chemistry, University of Wales Swansea, 1996


Following a PhD in medicinal chemistry, Sarah undertook postdoctoral research at Cardiff University, the University of Reading and Wake Forest University, USA. She has also worked as a medical writer for an international medical communications agency. 

Prior to joining the University of Birmingham in 2010, Sarah worked as a Research Facilitator at the University of Oxford Department for Continuing Education for more than three years. 

Sarah joined the University of Birmingham in 2010 as Research Administrator in Dentistry and recently undertook a secondment as Strategic Project Manager in the College of Medical and Dental Sciences.  Sarah is now providing secondment cover in the role of Operations Manager (Postgraduate Programmes). 

In this post, Sarah has overall administrative management responsibility for postgraduate research and postgraduate taught programmes in the College and works closely with the College Graduate Studies Director, Professor Steve Watson and administrative colleagues in the Schools dealing with recruitment & targets, admissions, registration, academic progress, leavers and new programme developments.


Poole, L.B., Klomsiri, C., Knaggs, S.A., Furdui, C.M., Nelson, K.J., Thomas, M.J., Fetrow, J.S., Daniel, L.W., King, S.B. (2007), Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins, Bioconjugate Chemistry, 18:2004-2017.

Poole, L.B., Zeng, B.B., Knaggs, S.A., Yakubu, M., King, S.B., (2005), Synthesis of chemical probes to map sulfenic acid modifications on proteins, Bioconjugate Chemistry, 16:1624-1628.

Knaggs, S., Malkin, H., Osborn, H.M.I, Williams, N.A.O, Yaqoob, P. (2005), New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT), Organic & Biomolecular Chemistry, 3:4002-4010.

McGuigan, C., Harris, S.A., Daluge, S.M., Gudmundsson, K.S., McLean, E.W., Burnette, T.C., et al. (2005), Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency, Journal of Medicinal Chemistry, 48: 3504-3515.

Harris, S.A., McGuigan, C., Andrei, G., Snoeck, R., De Clercq, E., Balzarini, J. (2001), Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)2 '-deoxyuridine, Antiviral Chemistry & Chemotherapy, 12: 293-300.

Knaggs, M.H., McGuigan, C., Harris, S.A., Heshmati, P., Cahard, D., Gilbert, I.H., Balzarini, J. (2000), A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T, Bioorganic & Medicinal Chemistry Letters, 10: 2075-2078.

McGuigan, C., Slater, M.J., Parry, N.R., Perry, A., Harris, S. (2000), Synthesis and antiviral activity of acyclovir-5 '-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug, Bioorganic & Medicinal Chemistry Letters, 10: 645-647.